Pharma & Healthcare
Beta-Lactam Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 656682
- Pages: 96
- Figures: 160
- Views: 1
The global market for Beta-Lactam Drugs was estimated to be worth US$ 28330 million in 2023 and is forecast to a readjusted size of US$ 34510 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Beta-Lactam Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Beta-Lactam Drugs by region & country, by Type, and by Application.
The Beta-Lactam Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Lactam Drugs.
Market Segmentation
By Company
GlaxoSmithKline plc
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Shionogi & Co., Ltd.
Segment by Type:
Penicillin
Cephalosporins
Carbapenem
Monobacteria
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Beta-Lactam Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Beta-Lactam Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Beta-Lactam Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Beta-Lactam Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Beta-Lactam Drugs by region & country, by Type, and by Application.
The Beta-Lactam Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Lactam Drugs.
Market Segmentation
By Company
GlaxoSmithKline plc
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Shionogi & Co., Ltd.
Segment by Type:
Penicillin
Cephalosporins
Carbapenem
Monobacteria
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Beta-Lactam Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Beta-Lactam Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Beta-Lactam Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Beta-Lactam Drugs Product Introduction
1.2 Global Beta-Lactam Drugs Market Size Forecast
1.3 Beta-Lactam Drugs Market Trends & Drivers
1.3.1 Beta-Lactam Drugs Industry Trends
1.3.2 Beta-Lactam Drugs Market Drivers & Opportunity
1.3.3 Beta-Lactam Drugs Market Challenges
1.3.4 Beta-Lactam Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Beta-Lactam Drugs Players Revenue Ranking (2023)
2.2 Global Beta-Lactam Drugs Revenue by Company (2019-2024)
2.3 Key Companies Beta-Lactam Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Beta-Lactam Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Beta-Lactam Drugs
2.6 Beta-Lactam Drugs Market Competitive Analysis
2.6.1 Beta-Lactam Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Beta-Lactam Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Penicillin
3.1.2 Cephalosporins
3.1.3 Carbapenem
3.1.4 Monobacteria
3.2 Global Beta-Lactam Drugs Sales Value by Type
3.2.1 Global Beta-Lactam Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Beta-Lactam Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Beta-Lactam Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Beta-Lactam Drugs Sales Value by Application
4.2.1 Global Beta-Lactam Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Beta-Lactam Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Beta-Lactam Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Beta-Lactam Drugs Sales Value by Region
5.1.1 Global Beta-Lactam Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Beta-Lactam Drugs Sales Value by Region (2019-2024)
5.1.3 Global Beta-Lactam Drugs Sales Value by Region (2025-2030)
5.1.4 Global Beta-Lactam Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Beta-Lactam Drugs Sales Value, 2019-2030
5.2.2 North America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Beta-Lactam Drugs Sales Value, 2019-2030
5.3.2 Europe Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Beta-Lactam Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Beta-Lactam Drugs Sales Value, 2019-2030
5.5.2 South America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Beta-Lactam Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Beta-Lactam Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Beta-Lactam Drugs Sales Value
6.3 United States
6.3.1 United States Beta-Lactam Drugs Sales Value, 2019-2030
6.3.2 United States Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Beta-Lactam Drugs Sales Value, 2019-2030
6.4.2 Europe Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Beta-Lactam Drugs Sales Value, 2019-2030
6.5.2 China Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Beta-Lactam Drugs Sales Value, 2019-2030
6.6.2 Japan Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Beta-Lactam Drugs Sales Value, 2019-2030
6.7.2 South Korea Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Beta-Lactam Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Beta-Lactam Drugs Sales Value, 2019-2030
6.9.2 India Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Profile
7.1.2 GlaxoSmithKline plc Main Business
7.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Products, Services and Solutions
7.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 GlaxoSmithKline plc Recent Developments
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Profile
7.2.2 Pfizer, Inc. Main Business
7.2.3 Pfizer, Inc. Beta-Lactam Drugs Products, Services and Solutions
7.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Pfizer, Inc. Recent Developments
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Profile
7.3.2 AstraZeneca plc Main Business
7.3.3 AstraZeneca plc Beta-Lactam Drugs Products, Services and Solutions
7.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Merck & Co., Inc. Recent Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Profile
7.4.2 Merck & Co., Inc. Main Business
7.4.3 Merck & Co., Inc. Beta-Lactam Drugs Products, Services and Solutions
7.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Merck & Co., Inc. Recent Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Profile
7.5.2 Eli Lilly and Company Main Business
7.5.3 Eli Lilly and Company Beta-Lactam Drugs Products, Services and Solutions
7.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Eli Lilly and Company Recent Developments
7.6 Shionogi & Co., Ltd.
7.6.1 Shionogi & Co., Ltd. Profile
7.6.2 Shionogi & Co., Ltd. Main Business
7.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Products, Services and Solutions
7.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Shionogi & Co., Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Beta-Lactam Drugs Industrial Chain
8.2 Beta-Lactam Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Beta-Lactam Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Beta-Lactam Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Beta-Lactam Drugs Product Introduction
1.2 Global Beta-Lactam Drugs Market Size Forecast
1.3 Beta-Lactam Drugs Market Trends & Drivers
1.3.1 Beta-Lactam Drugs Industry Trends
1.3.2 Beta-Lactam Drugs Market Drivers & Opportunity
1.3.3 Beta-Lactam Drugs Market Challenges
1.3.4 Beta-Lactam Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Beta-Lactam Drugs Players Revenue Ranking (2023)
2.2 Global Beta-Lactam Drugs Revenue by Company (2019-2024)
2.3 Key Companies Beta-Lactam Drugs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Beta-Lactam Drugs Product Offered
2.5 Key Companies Time to Begin Mass Production of Beta-Lactam Drugs
2.6 Beta-Lactam Drugs Market Competitive Analysis
2.6.1 Beta-Lactam Drugs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Beta-Lactam Drugs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Penicillin
3.1.2 Cephalosporins
3.1.3 Carbapenem
3.1.4 Monobacteria
3.2 Global Beta-Lactam Drugs Sales Value by Type
3.2.1 Global Beta-Lactam Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Beta-Lactam Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Beta-Lactam Drugs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Beta-Lactam Drugs Sales Value by Application
4.2.1 Global Beta-Lactam Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Beta-Lactam Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Beta-Lactam Drugs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Beta-Lactam Drugs Sales Value by Region
5.1.1 Global Beta-Lactam Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Beta-Lactam Drugs Sales Value by Region (2019-2024)
5.1.3 Global Beta-Lactam Drugs Sales Value by Region (2025-2030)
5.1.4 Global Beta-Lactam Drugs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Beta-Lactam Drugs Sales Value, 2019-2030
5.2.2 North America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Beta-Lactam Drugs Sales Value, 2019-2030
5.3.2 Europe Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Beta-Lactam Drugs Sales Value, 2019-2030
5.4.2 Asia Pacific Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Beta-Lactam Drugs Sales Value, 2019-2030
5.5.2 South America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Beta-Lactam Drugs Sales Value, 2019-2030
5.6.2 Middle East & Africa Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Beta-Lactam Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Beta-Lactam Drugs Sales Value
6.3 United States
6.3.1 United States Beta-Lactam Drugs Sales Value, 2019-2030
6.3.2 United States Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Beta-Lactam Drugs Sales Value, 2019-2030
6.4.2 Europe Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Beta-Lactam Drugs Sales Value, 2019-2030
6.5.2 China Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Beta-Lactam Drugs Sales Value, 2019-2030
6.6.2 Japan Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Beta-Lactam Drugs Sales Value, 2019-2030
6.7.2 South Korea Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Beta-Lactam Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Beta-Lactam Drugs Sales Value, 2019-2030
6.9.2 India Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Beta-Lactam Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Profile
7.1.2 GlaxoSmithKline plc Main Business
7.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Products, Services and Solutions
7.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.1.5 GlaxoSmithKline plc Recent Developments
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Profile
7.2.2 Pfizer, Inc. Main Business
7.2.3 Pfizer, Inc. Beta-Lactam Drugs Products, Services and Solutions
7.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.2.5 Pfizer, Inc. Recent Developments
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Profile
7.3.2 AstraZeneca plc Main Business
7.3.3 AstraZeneca plc Beta-Lactam Drugs Products, Services and Solutions
7.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.3.5 Merck & Co., Inc. Recent Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Profile
7.4.2 Merck & Co., Inc. Main Business
7.4.3 Merck & Co., Inc. Beta-Lactam Drugs Products, Services and Solutions
7.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.4.5 Merck & Co., Inc. Recent Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Profile
7.5.2 Eli Lilly and Company Main Business
7.5.3 Eli Lilly and Company Beta-Lactam Drugs Products, Services and Solutions
7.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.5.5 Eli Lilly and Company Recent Developments
7.6 Shionogi & Co., Ltd.
7.6.1 Shionogi & Co., Ltd. Profile
7.6.2 Shionogi & Co., Ltd. Main Business
7.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Products, Services and Solutions
7.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (US$ Million) & (2019-2024)
7.6.5 Shionogi & Co., Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Beta-Lactam Drugs Industrial Chain
8.2 Beta-Lactam Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Beta-Lactam Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Beta-Lactam Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Beta-Lactam Drugs Market Trends
Table 2. Beta-Lactam Drugs Market Drivers & Opportunity
Table 3. Beta-Lactam Drugs Market Challenges
Table 4. Beta-Lactam Drugs Market Restraints
Table 5. Global Beta-Lactam Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Beta-Lactam Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Beta-Lactam Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Beta-Lactam Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Beta-Lactam Drugs
Table 10. Global Beta-Lactam Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Beta-Lactam Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Beta-Lactam Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Beta-Lactam Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Beta-Lactam Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Beta-Lactam Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Beta-Lactam Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Beta-Lactam Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Beta-Lactam Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Beta-Lactam Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Beta-Lactam Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Beta-Lactam Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Beta-Lactam Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Beta-Lactam Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Beta-Lactam Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Beta-Lactam Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Beta-Lactam Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Beta-Lactam Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Beta-Lactam Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline plc Basic Information List
Table 32. GlaxoSmithKline plc Description and Business Overview
Table 33. GlaxoSmithKline plc Beta-Lactam Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Beta-Lactam Drugs Business of GlaxoSmithKline plc (2019-2024)
Table 35. GlaxoSmithKline plc Recent Developments
Table 36. Pfizer, Inc. Basic Information List
Table 37. Pfizer, Inc. Description and Business Overview
Table 38. Pfizer, Inc. Beta-Lactam Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Beta-Lactam Drugs Business of Pfizer, Inc. (2019-2024)
Table 40. Pfizer, Inc. Recent Developments
Table 41. AstraZeneca plc Basic Information List
Table 42. AstraZeneca plc Description and Business Overview
Table 43. AstraZeneca plc Beta-Lactam Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Beta-Lactam Drugs Business of AstraZeneca plc (2019-2024)
Table 45. AstraZeneca plc Recent Developments
Table 46. Merck & Co., Inc. Basic Information List
Table 47. Merck & Co., Inc. Description and Business Overview
Table 48. Merck & Co., Inc. Beta-Lactam Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Beta-Lactam Drugs Business of Merck & Co., Inc. (2019-2024)
Table 50. Merck & Co., Inc. Recent Developments
Table 51. Eli Lilly and Company Basic Information List
Table 52. Eli Lilly and Company Description and Business Overview
Table 53. Eli Lilly and Company Beta-Lactam Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Beta-Lactam Drugs Business of Eli Lilly and Company (2019-2024)
Table 55. Eli Lilly and Company Recent Developments
Table 56. Shionogi & Co., Ltd. Basic Information List
Table 57. Shionogi & Co., Ltd. Description and Business Overview
Table 58. Shionogi & Co., Ltd. Beta-Lactam Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Beta-Lactam Drugs Business of Shionogi & Co., Ltd. (2019-2024)
Table 60. Shionogi & Co., Ltd. Recent Developments
Table 61. Key Raw Materials Lists
Table 62. Raw Materials Key Suppliers Lists
Table 63. Beta-Lactam Drugs Downstream Customers
Table 64. Beta-Lactam Drugs Distributors List
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Beta-Lactam Drugs Product Picture
Figure 2. Global Beta-Lactam Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Beta-Lactam Drugs Report Years Considered
Figure 5. Global Beta-Lactam Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Beta-Lactam Drugs Revenue in 2023
Figure 7. Beta-Lactam Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Penicillin Picture
Figure 9. Cephalosporins Picture
Figure 10. Carbapenem Picture
Figure 11. Monobacteria Picture
Figure 12. Global Beta-Lactam Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Beta-Lactam Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital Pharmacies
Figure 15. Product Picture of Retail Pharmacies
Figure 16. Product Picture of Online Pharmacies
Figure 17. Global Beta-Lactam Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Beta-Lactam Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Beta-Lactam Drugs Sales Value (%), (2019-2030)
Figure 30. United States Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. China Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. China Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. India Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. India Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. Beta-Lactam Drugs Industrial Chain
Figure 52. Beta-Lactam Drugs Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Beta-Lactam Drugs Market Trends
Table 2. Beta-Lactam Drugs Market Drivers & Opportunity
Table 3. Beta-Lactam Drugs Market Challenges
Table 4. Beta-Lactam Drugs Market Restraints
Table 5. Global Beta-Lactam Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Beta-Lactam Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Beta-Lactam Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Beta-Lactam Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Beta-Lactam Drugs
Table 10. Global Beta-Lactam Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Lactam Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Beta-Lactam Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Beta-Lactam Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Beta-Lactam Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Beta-Lactam Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Beta-Lactam Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Beta-Lactam Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Beta-Lactam Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Beta-Lactam Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Beta-Lactam Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Beta-Lactam Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Beta-Lactam Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Beta-Lactam Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Beta-Lactam Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Beta-Lactam Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Beta-Lactam Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Beta-Lactam Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Beta-Lactam Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Beta-Lactam Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithKline plc Basic Information List
Table 32. GlaxoSmithKline plc Description and Business Overview
Table 33. GlaxoSmithKline plc Beta-Lactam Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Beta-Lactam Drugs Business of GlaxoSmithKline plc (2019-2024)
Table 35. GlaxoSmithKline plc Recent Developments
Table 36. Pfizer, Inc. Basic Information List
Table 37. Pfizer, Inc. Description and Business Overview
Table 38. Pfizer, Inc. Beta-Lactam Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Beta-Lactam Drugs Business of Pfizer, Inc. (2019-2024)
Table 40. Pfizer, Inc. Recent Developments
Table 41. AstraZeneca plc Basic Information List
Table 42. AstraZeneca plc Description and Business Overview
Table 43. AstraZeneca plc Beta-Lactam Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Beta-Lactam Drugs Business of AstraZeneca plc (2019-2024)
Table 45. AstraZeneca plc Recent Developments
Table 46. Merck & Co., Inc. Basic Information List
Table 47. Merck & Co., Inc. Description and Business Overview
Table 48. Merck & Co., Inc. Beta-Lactam Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Beta-Lactam Drugs Business of Merck & Co., Inc. (2019-2024)
Table 50. Merck & Co., Inc. Recent Developments
Table 51. Eli Lilly and Company Basic Information List
Table 52. Eli Lilly and Company Description and Business Overview
Table 53. Eli Lilly and Company Beta-Lactam Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Beta-Lactam Drugs Business of Eli Lilly and Company (2019-2024)
Table 55. Eli Lilly and Company Recent Developments
Table 56. Shionogi & Co., Ltd. Basic Information List
Table 57. Shionogi & Co., Ltd. Description and Business Overview
Table 58. Shionogi & Co., Ltd. Beta-Lactam Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Beta-Lactam Drugs Business of Shionogi & Co., Ltd. (2019-2024)
Table 60. Shionogi & Co., Ltd. Recent Developments
Table 61. Key Raw Materials Lists
Table 62. Raw Materials Key Suppliers Lists
Table 63. Beta-Lactam Drugs Downstream Customers
Table 64. Beta-Lactam Drugs Distributors List
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Beta-Lactam Drugs Product Picture
Figure 2. Global Beta-Lactam Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Beta-Lactam Drugs Report Years Considered
Figure 5. Global Beta-Lactam Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Beta-Lactam Drugs Revenue in 2023
Figure 7. Beta-Lactam Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Penicillin Picture
Figure 9. Cephalosporins Picture
Figure 10. Carbapenem Picture
Figure 11. Monobacteria Picture
Figure 12. Global Beta-Lactam Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Beta-Lactam Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital Pharmacies
Figure 15. Product Picture of Retail Pharmacies
Figure 16. Product Picture of Online Pharmacies
Figure 17. Global Beta-Lactam Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Beta-Lactam Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Beta-Lactam Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Beta-Lactam Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Beta-Lactam Drugs Sales Value (%), (2019-2030)
Figure 30. United States Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. China Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. China Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. India Beta-Lactam Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Beta-Lactam Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. India Beta-Lactam Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. Beta-Lactam Drugs Industrial Chain
Figure 52. Beta-Lactam Drugs Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232